Citadel Advisors’s KraneShares MSCI All China Health Care Index ETF KURE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-55,460
Closed -$947K 14347
2026
Q1
$947K Buy
55,460
+31,388
+130% +$556K ﹤0.01% 7783
2025
Q4
$410K Sell
24,072
-11,474
-32% -$219K ﹤0.01% 9489
2025
Q3
$744K Buy
+35,546
New +$699K ﹤0.01% 8197
2023
Q3
Sell
-11,463
Closed -$207K 14732
2023
Q2
$207K Buy
+11,463
New +$229K ﹤0.01% 9816
2022
Q4
Sell
-22,209
Closed -$394K 15200
2022
Q3
$394K Sell
22,209
-1,483
-6% -$30.9K ﹤0.01% 8975
2022
Q2
$554K Buy
23,692
+1,513
+7% +$31.8K ﹤0.01% 8422
2022
Q1
$517K Sell
22,179
-22,231
-50% -$546K ﹤0.01% 9311
2021
Q4
$1.27M Buy
+44,410
New +$1.53M ﹤0.01% 7305
2021
Q3
Sell
-14,265
Closed -$650K 14270
2021
Q2
$650K Buy
+14,265
New +$607K ﹤0.01% 9417
2020
Q1
Sell
-11,944
Closed -$276K 9919
2019
Q4
$276K Buy
+11,944
New +$271K ﹤0.01% 7718

Other funds holding KURE

Citadel Advisors's KURE Position: Q2 2026 in Review

Citadel Advisors sold out of KraneShares MSCI All China Health Care Index ETF (KURE) in Q2 2026, closing a stake of 55,460 shares — an estimated $947K sold.

Citadel Advisors first reported a position in KURE in Q4 2019 and held it in 10 quarters. The position peaked at $1.27M in Q4 2021. 13 funds tracked by Wall St. Rank hold KURE as of Q2 2026.

  • Citadel Advisors reported no remaining KraneShares MSCI All China Health Care Index ETF position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 55,460 KraneShares MSCI All China Health Care Index ETF shares in Q2 2026, an estimated $947K.
  • Citadel Advisors first reported a position in KraneShares MSCI All China Health Care Index ETF in Q4 2019 and held it in 10 quarters.
  • Citadel Advisors's KraneShares MSCI All China Health Care Index ETF position peaked at $1.27M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held KraneShares MSCI All China Health Care Index ETF as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.